selected publications
-
Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.
Circulation.
2024
Academic Article
GET IT
Times cited: 5 -
Long-term multicenter comparison shows equivalent efficacy of monoclonal antibodies in severe asthma therapy.
BMC pulmonary medicine.
2024
Academic Article
GET IT
Times cited: 2 -
Retrospective assessment and Biologic Asthma Response Score reveal roadmap for switching biologics in severe asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
2023
Letter
GET IT
Times cited: 3 -
Relationship Between the Response to Antibody Therapy and Symptoms of Depression and Anxiety Disorders in Patients with Severe Asthma.
Journal of asthma and allergy.
2023
Academic Article
GET IT
Times cited: 7 - The impact of anti-eosinophilic therapy on exercise capacity and inspiratory muscle strength in patients with severe asthma. ERJ open research. 2023 Academic Article GET IT
- [A cross-sectional study in three German hospitals regarding oxygen therapy characteristics]. Pneumologie (Stuttgart, Germany). 2022 Academic Article GET IT
-
[A cross-sectional study in three German hospitals regarding oxygen therapy characteristics].
Deutsche medizinische Wochenschrift (1946).
2022
Academic Article
GET IT
Times cited: 2 -
Overall Response to Anti-IL-5/Anti-IL5-Rα Treatment in Severe Asthma Does Not Depend on Initial Bronchodilator Responsiveness.
The journal of allergy and clinical immunology. In practice.
2022
Academic Article
GET IT
Times cited: 15 -
Clinical decision making is improved by BioFire Pneumonia Plus in suspected lower respiratory tract infection after lung transplantation: Results of the prospective DBATE-IT study.
Transplant infectious disease : an official journal of the Transplantation Society.
2021
Academic Article
GET IT
Times cited: 11 -
Graphic narrative based informed consent for bronchoscopy improves satisfaction in patients after lung-transplantation: A randomized controlled trial.
Patient education and counseling.
2021
Academic Article
GET IT
Times cited: 6 -
Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months.
Journal of asthma and allergy.
2021
Academic Article
GET IT
Times cited: 30 -
Characteristics and clinical implications of pleural effusions after lung transplantation: A retrospective analysis of 195 thoracocenteses in 113 patients.
Clinical transplantation.
2021
Academic Article
GET IT
Times cited: 5 -
Video Consultation During the COVID-19 Pandemic: A Single Center's Experience with Lung Transplant Recipients.
Telemedicine journal and e-health : the official journal of the American Telemedicine Association.
2020
Academic Article
GET IT
Times cited: 18 -
Dupilumab Improves Asthma Control and Lung Function in Patients with Insufficient Outcome During Previous Antibody Therapy.
The journal of allergy and clinical immunology. In practice.
2020
Academic Article
GET IT
Times cited: 56 -
Chronic progressive pulmonary paracoccidioidomycosis in a female immigrant from Venezuela.
2019
GET IT
Times cited: 5